CIBC Private Wealth Group’s AnaptysBio ANAB Stock Holding History

CIBC Private Wealth Group’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$48	Hold	1	–	–	﹤0.01%	3334
2025 Q3	$31	Buy	+1	New	+$23	﹤0.01%	3025

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CIBC Private Wealth Group's ANAB Position: Q4 2025 in Review

CIBC Private Wealth Group held its AnaptysBio (ANAB) position steady in Q4 2025 at 1 share worth $48. The position accounts for ﹤0.01% of the portfolio, ranked #3334.

CIBC Private Wealth Group first reported a position in ANAB in Q3 2025 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold ANAB as of Q4 2025.

CIBC Private Wealth Group held 1 share of AnaptysBio worth $48 as of Q4 2025.
CIBC Private Wealth Group left its AnaptysBio share count unchanged in Q4 2025.
AnaptysBio made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3334 holding.
CIBC Private Wealth Group first reported a position in AnaptysBio in Q3 2025 and has held it in 2 quarters since.
179 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.